RxDoctor Payments Data

PRALUENT: cost and payments to doctors

What Medicare Part D paid pharmacies for PRALUENT, and the payments that named it as the associated drug or biological under the Sunshine Act for program years 20192025.

Part D cost for PRALUENT formulations

Medicare reports PRALUENT under its specific formulations, which are priced separately.

  • praluent pen$496per 30-day fill · 326,519 claims · Alirocumab

Paid to pharmacies by Part D plans and patients — not your cost, and not paid to the prescriber. Is this wrong?

Was your doctor paid by Sanofi-aventis U.S. LLC?

Sanofi-aventis U.S. LLC reported the most payments naming PRALUENT. Search your clinician to see whether they are among them — and what else they were paid for.

Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.

Total reported
$5.1M
Providers
14,561
Transactions
53,819
Average per transaction
$95

The per-transaction average — $95 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 14,561 providers the average total is $352, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Sanofi-aventis U.S. LLC$3,219,96162.8%
Regeneron Healthcare Solutions, Inc.$1,268,55124.7%
Regeneron$532,13210.4%
Sanofi US Services Inc.$107,1492.1%
Sanofi$1,0000.0%

Other products from Sanofi-aventis U.S. LLC

The company that reported the most payments naming PRALUENT also reports against these.

← All drugs & devices